Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Amneal Pharmaceuticals announced a 10-year license and supply agreement for Levothyroxine sodium tablets with Jerome Stevens Pharmaceuticals.
read more
Wednesday, August 26, 2015
Amneal has announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC. Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals.
read more
Amneal announced a 5-year supply and distribution agreement with American Regent for the preservative-free generic alternative to Makena.
read more
Amneal Pharmaceuticals has announced a restructuring plan designed to reduce its cost base to and optimize its global manufacturing infrastructure.
read more
Amneal announced its Co-Founders, Chirag Patel and Chintu Patel, have been named Co-Chief Executive Officers, effective immediately.
read more
Wednesday, November 13, 2019
Amneal Pharmaceuticals is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level.
read more
Wednesday, August 19, 2015
Amneal Pharmaceuticals has announced the launch of aripiprazole oral solution in 1 mg/mL strength.
read more
Thursday, February 01, 2018
Amneal Pharmaceuticals has launched isotretinoin capsules, USP, an AB-rated generic for Accutane in 10 mg, 20 mg, 30 mg and 40 mg strengths.
read more
Amneal Pharmaceuticals announced Thursday Tasos Konidaris was appointed as senior vice president, chief financial officer, effective March 12.
read more
Wednesday, January 20, 2016
AMPAC Fine Chemicals LLC has announced the appointment ofAslam Malik, Ph.D., to the position of President and Chief Executive Officer (CEO) effective January 1, 2016.
read more
AMPAC Fine Chemicals announced Lee Gauthier has joined AFC's executive team as Vice President of Operations responsible for manufacturing across all AFC's sites.
read more
Tuesday, October 24, 2017
AMPAC Fine Chemicals announced Don Whiteaker has been promoted to Vice President, Supply Chain and Dr. Jeff Butler has been promoted to Executive Director, Project Management.
read more
AMPAC Fine Chemicals LLC (AFC) reports their "AMPAC Analytical" Business Unit has recently quadrupled their Analytical Services capacity to meet significantly growing customer demand for highly specialized testing. AMPAC Analytical has added 13,000 ...
read more
AMPAC Fine Chemicals (AFC) has announced that Joe Campbell has been promoted to the position of Vice President of Operations and Engineering, and Frank Mueller has been promoted to the position of Director, Lean Enterprise and Operational Excellence...
read more
Wednesday, January 03, 2024
Ampersand Biomedicines has acquired AbCheck s.r.o., a technology company specializing in antibody discovery for challenging targets and formerly a wholly-owned subsidiary of Affimed GmbH. Ampersand, a multi-product platform company focused on ...
read more